Cargando…
Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction
BACKGROUND AND PURPOSE: Up to 50–60% of all cancer patients receive radiotherapy as part of their treatment strategy. However, the mechanisms accounting for increased vascular risks after irradiation are not completely understood. Mitochondrial dysfunction has been identified as a potential cause of...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082323/ https://www.ncbi.nlm.nih.gov/pubmed/32231569 http://dx.doi.org/10.3389/fphar.2020.00268 |